RNAZ$1.635.78%-0.10
After Hours: 1.52-0.11 -6.75%
Transcode Therapeutics Inc (RNAZ)
Date: 2026-10-30 16:00O: 1.73H: 1.79L: 1.62C: 1.63Vol: 16.09k
Transcode Therapeutics Inc stock is traded at $1.63, with a volume of 16,086. It is down -5.78% in the last 24 hours and down -2.98% over the past month. TransCode Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of RNA-based therapeutics and immuno-oncology treatments for cancer. The company's lead candidate, TTX-MC138, targets microRNA-10b and has completed a Phase 1a clinical trial, while it is also advancing additional product candidates, including a cancer vaccine and an oncolytic immunotherapy platform.
Previous Close:
$1.73
Open:
$1.73
24h Volume:
16,086
Relative Volume:
0.61
Market Cap:
$27.60M
Revenue:
-
Net Income/Loss:
-$40.36M
P/E Ratio:
-
EPS:
-$48.65
Net Cash Flow:
-$21.40M
1W Performance:
-7.91%
1M Performance:
-2.98%
6M Performance:
-79.65%
1Y Performance:
-85.11%
1-Day Range:
$1.62$1.79
1-Week Range:
$1.61$1.91
52-Week Range:
$1.52$13.96
Transcode Therapeutics Inc Stock (RNAZ) Company Profile
Name
Transcode Therapeutics IncSector
HealthcareIndustry
BiotechnologyPhone
857-301-6857Address
6 LIBERTY SQUARE, BOSTON, USACompare RNAZ vs VRTX, REGN, MRNA, ARGX, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RNAZ Transcode Therapeutics Inc | $1.63 | $27.60M | $0 | -$40.36M | -$21.40M | -$48.65 |
 VRTX Vertex Pharmaceuticals Inc | $558.88 | $141.65B | $12.34B | $4.34B | $3.71B | $16.87 |
 REGN Regeneron Pharmaceuticals Inc | $927.89 | $95.53B | $14.92B | $4.42B | $3.79B | $41.04 |
 MRNA Moderna Inc | $221.72 | $88.52B | $2.23B | -$3.19B | -$1.60B | -$8.15 |
 ARGX Argen X Se Adr | $892.87 | $56.15B | $4.16B | $1.29B | $734.26M | $19.58 |
 ONC Beone Medicines Ltd Adr | $370.33 | $41.89B | $5.76B | $514.49M | $1.10B | $4.48 |
Transcode Therapeutics Inc Stock (RNAZ) Financials Data
Revenue
Chart is being upgraded
This chart will be back soon.
